| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 11/19/2009 | US20090285908 Method of treating endothelial injury |
| 11/19/2009 | US20090285902 Dietary supplement composition for blood lipid health |
| 11/19/2009 | US20090285893 Treatment of heart failure in women |
| 11/19/2009 | US20090285816 Albumin Fusion Proteins |
| 11/19/2009 | US20090285811 Anti-inflammatory and immunosuppressive glucocorticoid steroids |
| 11/19/2009 | US20090285787 Intracoronary, intracardia, or intravenous infusion of a mixture of autologous bone marrow derived mononuclear cells and autologous bone marrow derived mesenchymal stem cells for utilization and rescue of infarcted myocardium |
| 11/19/2009 | US20090285753 Novel haptotactic peptides |
| 11/19/2009 | DE112007003136T5 Ein Extrakt An extract |
| 11/19/2009 | CA2724540A1 Treating dyspnea associated with acute heart failure with relaxin |
| 11/19/2009 | CA2724535A1 Method of treating chronic heart failure |
| 11/19/2009 | CA2724442A1 A drilling rig and a method for moving a drilling rig |
| 11/19/2009 | CA2724435A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 11/19/2009 | CA2724077A1 Amide compound |
| 11/19/2009 | CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group |
| 11/19/2009 | CA2723922A1 Purine derivatives further comprising a mercapto-acylamino group as neutral endopeptidase inhibitors |
| 11/19/2009 | CA2723826A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperazine derivatives |
| 11/19/2009 | CA2723767A1 Novel uses of d-mannopyranose derivatives activating angiogenesis |
| 11/18/2009 | EP2119719A1 Thiazepine derivative |
| 11/18/2009 | EP2119718A1 Macrocyclic compound |
| 11/18/2009 | EP2119715A1 Benzimidazole derivative and its use as aii receptor antagonist |
| 11/18/2009 | EP2119702A1 Amide derivative |
| 11/18/2009 | EP2119443A1 Composition for prevention or treatment of disease associated with thrombus or embolus |
| 11/18/2009 | EP2119441A1 Use of angiotensin II receptor antagonists in order to increase insulin sensitivity |
| 11/18/2009 | EP2119437A1 Device for the transdermal administration of bisoprolol |
| 11/18/2009 | EP2118093A1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
| 11/18/2009 | EP2118074A1 Compounds for the prevention and treatment of cardiovascular diseases |
| 11/18/2009 | EP2118073A2 Selective endothelin type-a antagonists |
| 11/18/2009 | EP2117582A2 Periostin induces proliferation of cardiomyocytes and promotes cardiac regeneration |
| 11/18/2009 | EP2117561A1 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
| 11/18/2009 | EP2117551A1 Levosimendan for use in treating chronic valvular disease |
| 11/18/2009 | EP2117550A1 Use of ranolazine for the treatment of non-coronary microvascular diseases |
| 11/18/2009 | EP2117549A1 Use of ranolazine for the treatment of coronary microvascular diseases |
| 11/18/2009 | EP2117524A1 Use of catecholamines and related compounds as anti-angiogenic agents |
| 11/18/2009 | EP2117509A1 Use of ranolazine for the treatment of cardiovascular diseases |
| 11/18/2009 | EP2117330A1 Process for the preparation of angiogenin |
| 11/18/2009 | EP1971610B1 Salts of clopidogrel with polyanions and their use for manufacturing pharmaceutical formulations |
| 11/18/2009 | EP1928842B1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 11/18/2009 | EP1910340B1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 11/18/2009 | EP1893609B1 N-(pyridin-2-yl)-sulfonamide derivatives |
| 11/18/2009 | EP1873148B1 Pharmaceutical compositions containing crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid |
| 11/18/2009 | EP1529049B1 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 11/18/2009 | EP1490064B1 Substituted pyridinones as modulators of p38 map kinase |
| 11/18/2009 | EP1463541B1 Biomaterials based on hyaluronic acid benzyl ester for the anti-angiogenic therapy in the treatment of tumours |
| 11/18/2009 | EP1397357B9 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 11/18/2009 | EP1358172B1 Amino ceramide-like compounds and therapeutic methods of use |
| 11/18/2009 | EP1292671B1 Method for obtaining characterised muscle-derived cell populations and uses |
| 11/18/2009 | EP1280781B1 5-ht 7 receptor antagonists |
| 11/18/2009 | EP0957901B1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 11/18/2009 | EP0892789B2 Irreversible inhibitors of tyrosine kinases |
| 11/18/2009 | EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators |
| 11/18/2009 | CN101583615A Spiropiperidine glycinamide derivatives |
| 11/18/2009 | CN101583609A Indoles |
| 11/18/2009 | CN101583598A Novel indole derivative having inhibitory activity on i kappa b kinase ss |
| 11/18/2009 | CN101583355A Renin inhibitors for the prevention and treatment of hypertension in obese patients |
| 11/18/2009 | CN101580525A Method for extracting salidroside, polysaccharose and tannin-type substances from rhodiola root crude drugs |
| 11/18/2009 | CN101580512A Novel xyloketal compound in marine fungal from South China Sea and application thereof in preparation of antihypertensive drugs |
| 11/18/2009 | CN101580511A Application of novel xyloketal compound in marine fungal from South China Sea in preparation of intracellular anti-oxidation stress medicine |
| 11/18/2009 | CN101580505A Derivatives of pyrrolo[2,1-b]quinazoline natural products, preparation method and application thereof |
| 11/18/2009 | CN101580466A Preparation method of sodium salt of pravastatin |
| 11/18/2009 | CN101579509A Traditional Chinese medicine preparation for treating premature beat of cardiac rhythm |
| 11/18/2009 | CN101579492A Medicine for treating high blood pressure and preparation method thereof |
| 11/18/2009 | CN101579487A Capsule for treating bones and muscles |
| 11/18/2009 | CN101579481A Medicinal composition for treating hypertension |
| 11/18/2009 | CN101579480A Medicinal dripping pill for treating hypertension |
| 11/18/2009 | CN101579434A Traditional Chinese medicine preparation for curing femoral head necrosis and vasculitis |
| 11/18/2009 | CN101579400A Preparing method of preparation for preventing and treating cardiovascular and cerebrovascular diseases |
| 11/18/2009 | CN101579394A Trichosanthes bark dropping pill and preparation method thereof |
| 11/18/2009 | CN101579376A Diol saponin traditional Chinese medicine preparation and preparation method thereof |
| 11/18/2009 | CN101579361A Complex probiotics for curing hypertension and coronary heart disease and preparation method thereof |
| 11/18/2009 | CN101579356A Deproteinated calf blood ingredient brain targeting nanosphere and preparation method thereof |
| 11/18/2009 | CN101579346A Medicine composition and medicine box set and application thereof |
| 11/18/2009 | CN101579335A New formulation of medicament, preparation method and application method |
| 11/18/2009 | CN101579332A Pharmaceutical composition for treating cardiovascular disease and application thereof |
| 11/18/2009 | CN101579331A Application of alpha-ketoglutarate magnesium in preparing medicament for resisting heart and cerebral ischemia |
| 11/18/2009 | CN101579329A Bevantolol hydrochloride sustained release preparation |
| 11/18/2009 | CN101579323A Butylphenyl phthaleine sustained release tablet and preparation method thereof |
| 11/18/2009 | CN101579319A Medical prescription of catalpol freezing-drying powder for injection and preparation method |
| 11/18/2009 | CN101579291A Resveratrol phospholipid composite nano-emulsion and preparation method and application thereof |
| 11/18/2009 | CN101579027A Health-care tea for reducing and stabilizing blood pressure |
| 11/18/2009 | CN100560589C Imidazoselenazole compounds and their use for prevention and/or treatment of diseases relative to protein aging |
| 11/18/2009 | CN100560585C New benzimidazole derivative |
| 11/18/2009 | CN100560569C Lotus plumule alkaloid extract and its preparation process and use in preparation of drugs for cardiovascular and cerebrovascular diseases |
| 11/18/2009 | CN100560114C Chinese medicine capsule for treating coronary heart disease |
| 11/18/2009 | CN100560107C Traditional Chinese medicine composition, its preparation and quality controlling means |
| 11/18/2009 | CN100560103C Ointment of diminishing gore and preparing method |
| 11/18/2009 | CN100560095C Compound preparation containing extractive of almond and extractive of ginkgo leaf |
| 11/18/2009 | CN100560093C Capsule consisting of five kinds of ingredients for treating piles and method for preparing same |
| 11/18/2009 | CN100560090C Methods of acquiring total tanshinone and total phenolic acid |
| 11/18/2009 | CN100560083C Preparation method for extracting purified general saponin from notoginseng of Chinese traditional medicine |
| 11/18/2009 | CN100560081C Method for extracting flavonoids from the waxberry core |
| 11/18/2009 | CN100560079C Injection solution of Chinese traditional medicine for treating hemorrhoid |
| 11/18/2009 | CN100560074C External patch containing estrogen and/or progestogen |
| 11/18/2009 | CN100560072C Hydrochloric acid olprinone injection and method for preparing the same |
| 11/18/2009 | CN100560067C Hydrochloric acid dronedarone medicinal compositions for oral use and method for preparing the same |
| 11/17/2009 | US7619100 Physiologically active substances |
| 11/17/2009 | US7619097 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 11/17/2009 | US7619082 Process for the preparation of 3-spiro′cyclohexan-1,3′-′3H!indolin-2′-one! derivatives |
| 11/17/2009 | US7619065 Cystine-knot fold protein |
| 11/17/2009 | US7619002 Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events |
| 11/17/2009 | US7618961 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |